Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, B-Cell 2 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Lymphoma 1

Interventions

Rituximab 112 Cyclophosphamide 103 fludarabine 61 Doxorubicin 33 Vincristine 31 Etoposide 31 Prednisone 30 Lenalidomide 24 ibrutinib 22 fludarabine phosphate 21 Immunotherapy, Adoptive 19 Bendamustine Hydrochloride 19 obinutuzumab 18 Cytarabine 18 pembrolizumab 16 Magnetic Resonance Spectroscopy 16 Bortezomib 14 Specimen Handling 13 Dexamethasone 13 polatuzumab vedotin 12 CT-P10 12 venetoclax 11 pirtobrutinib 11 Gemcitabine 11 Carboplatin 11 glofitamab 10 zanubrutinib 9 Nivolumab 9 Mycophenolic Acid 9 Melphalan 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, B-Cell × spebrutinib × Clear all

NCT01766583 2018-03-07

CLEAR

The Lymphoma Academic Research Organisation

Phase 1 Completed

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡